The largest database of trusted experimental protocols

Oncentra brachy

Manufactured by Elekta
Sourced in Sweden

Oncentra Brachy is a comprehensive brachytherapy treatment planning system developed by Elekta. Its core function is to provide advanced treatment planning capabilities for brachytherapy procedures, which involve the precise placement of radioactive sources inside or near a tumor.

Automatically generated - may contain errors

Lab products found in correlation

10 protocols using oncentra brachy

1

Iridium-192 HDR Brachytherapy Applicator

Check if the same lab product or an alternative is used in the 5 most similar protocols
HDR brachytherapy has for a long time been used for the treatment of prostatic and gynecological cancer 15, 16 . The current isotope is Iridium 192, which is the most commonly used isotope for HDR brachytherapy applications. This is also the isotope used in this study. A reusable applicator of a plastic material, PEEK ® , shaped according to the anisotropic radiation dose distribution was developed (Fig. 1). The applicator was attached to a pole approved to be connected to a MicroSelectron ® HDR machine (Elekta AB, Stockholm, Sweden). Five sets of applicators with a diameter of 25, 30, 35, 40, and 50 mm respectively were constructed. A single dose of 20 Gy, prescribed at the applicator surface, was delivered in the wound cavity. The dose fall from the applicator surface varied due to the diameter of the applicator (Table 2). A medical physicist calculated the treatment time from a dose-plan library based on source strength and applicator dimension.
The 10-Gy isodose volume outside the applicator was determined using planning CT and the treatment planning system Oncentra Brachy ® (Elekta AB) (Fig. 3). Air cavities inside this shell were outlined, and their volumes were calculated as a measure of the tissue adaption to the applicator.
+ Open protocol
+ Expand
2

CT-Guided Brachytherapy Catheter Placement

Check if the same lab product or an alternative is used in the 5 most similar protocols
The placement of brachytherapy catheters (Primed Halberstadt Medizintechnik, Halberstadt, Germany) was performed CT-guided by an experienced interventional radiologist. A dedicated planning CT was acquired with a slice thickness of 2mm, and i.v. contrast was administered, if applicable. For treatment planning, the CT dataset was transferred to the treatment planning software Oncentra Brachy (Elekta AB, Stockholm, Sweden) version 4.5.2. The clinical target volume (CTV) and adjacent organs at risk were delineated by a radiation oncologist. The 3D catheter reconstruction was performed using the hyperdense tip marker of the BT catheter as reference point. For dose optimization, a dwell point step width of 2 mm was defined. Dose optimization was performed manually by a medical physicist using a prescribed dose of 15 Gy to 100% of the target volume (D100), example shown in Figure 1. Organs-at-risk dose constraints were given as follows: bowel/colon and stomach D1 ccm: 12 Gy, D0.1 ccm: 15 Gy; esophagus D1 ccm: 12 Gy, D0.01 ccm: 15 Gy; spinal cord D0.01 ccm: 10 Gy; skin D0.01 ccm: 10 Gy. One-third of the uninvolved liver was irradiated with less than 5 Gy.
+ Open protocol
+ Expand
3

Dosimetric Evaluation of ISBT for Tongue Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Under institutional review board approval, 30 patients with tongue cancer treated with ISBT between September 2018 and August 2021 were evaluated. Planning target volume (PTV) was defined as the same as gross tumor volume (GTV). The mean ± standard deviation (SD) of the PTV was 11.7 ± 7.9 cm3 (range, 2.7–28.6 cm3). Needles were inserted under the jaw into the oral cavity and replaced with flexible plastic catheters. The number of applicators used was 5.9 ± 2.4 (range, 3–14). All patients were treated with a spacer made of resin inserted between the mandible and tongue. A 3-mm-thick LB was inserted into the spacer (Fig. 1). Details of the spacer with the lead block are described elsewhere [7 (link)]. The LB was removed during image acquisition of the planning CT to avoid the effects of metal artifacts. The Oncentra Brachy (Elekta, Stockholm, Sweden) TPS was used for treatment planning. The prescribed dose was 54 Gy/9 fractions/5 days [14 (link)]. Graphical optimization was used to improve PTV coverage and reduce the mandibular dose.

Photographs of the spacer containing the lead block

+ Open protocol
+ Expand
4

Interstitial Brachytherapy Boost for Cervical Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients were initially treated with external beam radiotherapy using the four-field box technique with a total dose of 45 Gy in 25 fractions followed by interstitial BT (ISBT) boost treatment. For ISBT, a perineal template (Best Medical, Springfield, Virginia) was used with a 2.2 cm diameter vaginal cylinder and a combination of intracavitary and interstitial 6 F 24 cm plastic catheters. Three or four BT fractions were delivered with a target dose of 700 cGy per fraction. Target volumes and organs at risk (OAR) were defined on CT images. Plans were produced using the Oncentra Brachy (Elekta AB, Stockholm, Sweden) treatment planning system.
+ Open protocol
+ Expand
5

BT Planning Protocol Comparison

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the BT planning, an Oncentra Brachy (Elekta, Veenendaal, Netherlands) RTplan file with applicator reconstruction was provided allowing all participants to use the same applicator reconstruction and thereby facilitating a fair plan comparison. All participants except one used Oncentra Brachy in their clinic.
The following dose points were to be placed: points A, ICRU bladder, Lateral Vaginal points at 5 mm, and Recto-Vaginal Reference Point (RVRP) [19] (link), [20] (link). Three plans were required: (1) a generic “standard plan”, consisting of a set of pre-determined dwell times and positions, (2) a centre-specific “centre standard plan” (not optimized), and (3) an optimized plan according to the aims and constraints of the EMBRACE-II protocol. DVH parameters for all plans, DICOM RTdose and RTplan for the optimized plan were returned. For the second workshop the coordinates of the dose points were distributed and only an optimized plan was requested.
+ Open protocol
+ Expand
6

Extracting Ground-Truth Applicator Segmentation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two additional pre-processing steps were performed on the DICOM data after export. First, the contours of the applicator, which are usually not available in the TPS (Oncentra® Brachy – Elekta, Venendaal), were generated with an Elekta Applicator Slicer research plugin (Elekta, Venendaal) and treated as ground-truth masks. The plugin used the MRI and treatment plan with reconstructed applicator model to generate a standard radiotherapy (RT) structure file for the intracavitary applicator geometry. The resulting applicator mask was further processed with a hole filling algorithm to create continuous applicator geometries [17] .
It is important to note that, even if the plugin was commercially available, the described method to extract these ground-truth segmentations would not be feasible for an automatic workflow, as it requires prior manual placement of an applicator library model.
Second, a python script was written to read and export all available dwell positions of the applicator from the treatment plan for the purpose of evaluating registration performance. Dwell positions were exported as x,y,z-coordiantes in the patient coordinate system. Only clinically relevant dwell positions were considered for the calculation of the registration error. (Fig. 1, Appendix Table A1).

3D visualization of the exported applicator dwell positions in the patient coordinate system.

+ Open protocol
+ Expand
7

Customized Surface Mould Brachytherapy Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The treatment protocol of the Brachytherapy Department of Maria Sklodowska-Curie National Research Institute of Oncology (MSCNRIO), Gliwice Branch, was developed over the last three decades of experience in the field. It has commonalities with The Groupe Européen de Curiethérapie of the European Society for Radiotherapy & Oncology (GEC-ESTRO) recommendations [22 (link)], but there are some differences, i.e., maximal surface dose, mould thickness and fractionation. The schedule is nine fractions of 5Gy delivered to the tumour with a 5 mm margin. The treatment was prescribed three times a week to a total dose of 45 Gy. Custom-made surface mould polyacrylamide applicators precisely covering the treatment area were prepared. On the surface of the applicator, plastic tubes were glued for Iridium 192 HDR radioactive source loading. The position of the source and time of treatment was planned by a medical physicist with OncentraBrachy (Elekta AB, Stockholm, Sweden) software (version 4.6.0), using computed tomography images of the treatment area with an attached applicator. The study protocol was approved by the Local Ethics Committee (KB/430-41/20). All patients gave written informed consent.
+ Open protocol
+ Expand
8

Adaptive HDREBT for Cervical Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients were treated with 13 Â 3 Gy EBRT at four fractions per week, followed by three weekly fractions of HDREBT using a prescription dose of 5e8 Gy starting 6 weeks after conclusion of EBRT. We adapted the brachytherapy equipment, application and positioning procedures from Devic et al. as described in Rijkmans et al. (8, 11) . Patients received an enema before the CT scan with applicator in situ at each fraction.
We acquired a planning CT scan with applicator in situ before the first fraction. An inflatable balloon around the applicator on the opposite side of the clinical target volume (CTV) was used to fixate the applicator and to decrease the dose to the normal rectal wall. Treatment planning was performed using Oncentra Brachy (Elekta, Veenendaal, The Netherlands). The aim for treatment planning was to cover the CTV with the 100% isodose while containing the 400% isodose within the applicator. Repeat CT scans with applicator in situ were acquired for research purposes. In case of obvious differences compared to the CT scan of the first fraction, the treatment plan was adapted accordingly. These adapted treatment plans were not used in this study.
+ Open protocol
+ Expand
9

Brachytherapy Caps Design Pre-Plan Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this work, Oncentra Brachy (Elekta, Stockholm, Sweden) was used to create a caps design pre-plan, which consisted of two components (Figure 3A). The first component involved a manual reconstruction of the split ring channels over a length of ~35 mm. The second component required manually reconstructing IS needle virtual trajectories based on a visualization of important target structures. These virtual trajectories should extend at least ±1 cm from the split ring channels in the superior/inferior direction and intersect important target structures. Dummy dwell positions were then activated every 5 mm to complete the caps design pre-plan, which was imported into 3D Brachy as a DICOM-RT Plan file.
+ Open protocol
+ Expand
10

Oncentra Brachy TPS Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The TPS in which the clinically accepted plans for the patient group were created was Oncentra Brachy (version 4.3 or 4.5, Elekta AB., Stockholm, Sweden). In the TPS, DV indices were computed and evaluated in the “Brachy Planning” module.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!